UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 2.273

Sortiert nach

Sex-dependent effects of the uncompetitive N-methyl-D-aspartate receptor antagonist REL-1017 in G93A-SOD1 amyotrophic lateral sclerosis mice

Frontiers in neurology, 2024-05, Vol.15, p.1384829-1384829

2024

Link zum Volltext

Verfügbarkeit prüfen

Esmethadone-HCl (REL-1017): a promising rapid antidepressant

European archives of psychiatry and clinical neuroscience, 2023-10, Vol.273 (7), p.1463-1476

2023

Link zum Volltext

Verfügbarkeit prüfen

Behavioral Demonstration of a Somatosensory Neuroprosthesis

IEEE transactions on neural systems and rehabilitation engineering, 2013-05, Vol.21 (3), p.500-507

2013

Link zum Volltext

Verfügbarkeit prüfen

Influence of the addition of montmorillonite to the matrix of unidirectional glass fibre/epoxy composites on their mechanical and water absorption properties

Composites. Part A, Applied science and manufacturing, 2008-11, Vol.39 (11), p.1726-1731

2008

Link zum Volltext

Verfügbarkeit prüfen

Fully bio-based and biodegradable polylactic acid/poly(3-hydroxybutirate) blends: Use of a common plasticizer as performance improvement strategy

Polymer testing, 2016-02, Vol.49, p.22-28

2016

Link zum Volltext

Verfügbarkeit prüfen

REL-1017 (esmethadone; d-methadone) does not cause reinforcing effect, physical dependence and withdrawal signs in Sprague Dawley rats

Scientific reports, 2022-07, Vol.12 (1), p.11389-11389, Article 11389

2022

Link zum Volltext

Verfügbarkeit prüfen

Enhancement of paperboard performance as packaging material by layering with plasticized polyhydroxybutyrate/nanocellulose coatings

Journal of applied polymer science, 2018-12, Vol.135 (48), p.n/a

2018

Link zum Volltext

Verfügbarkeit prüfen

Influence of organically modified clays on the properties and disintegrability in compost of solution cast poly(3-hydroxybutyrate) films

Polymer degradation and stability, 2014-01, Vol.99, p.127-135

2014

Link zum Volltext

Verfügbarkeit prüfen

The novel uncompetitive NMDA receptor antagonist esmethadone (REL-1017) has no meaningful abuse potential in recreational drug users

Translational psychiatry, 2023-06, Vol.13 (1), p.192-12, Article 192

2023

Link zum Volltext

Verfügbarkeit prüfen

Bilayer biocomposites based on coated cellulose paperboard with films of polyhydroxybutyrate/cellulose nanocrystals

Cellulose (London), 2018-04, Vol.25 (4), p.2419-2434

2018

Link zum Volltext

Verfügbarkeit prüfen

Imaging Systems for GI Endoscopy, and Graphs in Biomedical Image Analysis: First MICCAI Workshop, ISGIE 2022, and Fourth MICCAI Workshop, GRAIL 2022, Held in Conjunction with MICCAI 2022, Singapore, September 18, 2022, Proceedings

1, 2022

Link zum Volltext

Verfügbarkeit prüfen

Esmethadone (REL-1017) and Other Uncompetitive NMDAR Channel Blockers May Improve Mood Disorders via Modulation of Synaptic Kinase-Mediated Signaling

International journal of molecular sciences, 2022-10, Vol.23 (20), p.12196

2022

Link zum Volltext

Verfügbarkeit prüfen

REL-1017 (Esmethadone), A Novel NMDAR Blocker for the Treatment of MDD is Not Neurotoxic in Sprague-Dawley Rats

Frontiers in pharmacology, 2022-04, Vol.13, p.863959-863959

2022

Link zum Volltext

Verfügbarkeit prüfen

Effect of Natural Glyceryl Tributyrate as Plasticizer and Compatibilizer on the Performance of Bio-Based Polylactic Acid/poly(3-hydroxybutyrate) Blends

Journal of polymers and the environment, 2019-07, Vol.27 (7), p.1429-1438

2019

Link zum Volltext

Verfügbarkeit prüfen

Impact of different nanoparticles on the thermal degradation kinetics of phenolic resin nanocomposites

Journal of thermal analysis and calorimetry, 2017-06, Vol.128 (3), p.1463-1478

2017

Link zum Volltext

Verfügbarkeit prüfen

REL-1017 (Esmethadone) Increases Circulating BDNF Levels in Healthy Subjects of a Phase 1 Clinical Study

Frontiers in pharmacology, 2021-04, Vol.12, p.671859-671859

2021

Link zum Volltext

Verfügbarkeit prüfen

Myostatin promotes distinct responses on protein metabolism of skeletal and cardiac muscle fibers of rodents

Brazilian journal of medical and biological research, 2017-12, Vol.50 (12), p.e6733-e6733

2017

Link zum Volltext

Verfügbarkeit prüfen

Polyhydroxybutyrate-Based Nanocomposites with Cellulose Nanocrystals and Bacterial Cellulose

Journal of polymers and the environment, 2017-09, Vol.25 (3), p.586-598

2017

Link zum Volltext

Verfügbarkeit prüfen

Drug–Drug Interaction Studies of Esmethadone (REL-1017) Involving CYP3A4- and CYP2D6-Mediated Metabolism

Drugs in R&D, 2024-03, Vol.24 (1), p.51-68

2024

Link zum Volltext

Verfügbarkeit prüfen

Ternary nanocomposites based on plasticized poly(3-hydroxybutyrate) and nanocellulose

Polymer bulletin (Berlin, Germany), 2019-02, Vol.76 (2), p.967-988

2019

Link zum Volltext

Verfügbarkeit prüfen

The N-Methyl-D-Aspartate Receptor Blocker REL-1017 (Esmethadone) Reduces Calcium Influx Induced by Glutamate, Quinolinic Acid, and Gentamicin

Pharmaceuticals (Basel, Switzerland), 2022-07, Vol.15 (7), p.882

2022

Link zum Volltext

Verfügbarkeit prüfen

Non-isothermal crystallization kinetics from the melt of nanocomposites based on poly(3-hydroxybutyrate) and modified clays

Thermochimica acta, 2014-10, Vol.594, p.80-88

2014

Link zum Volltext

Verfügbarkeit prüfen

Pharmacological Comparative Characterization of REL-1017 (Esmethadone-HCl) and Other NMDAR Channel Blockers in Human Heterodimeric N-Methyl-D-Aspartate Receptors

Pharmaceuticals (Basel, Switzerland), 2022-08, Vol.15 (8), p.997

2022

Link zum Volltext

Verfügbarkeit prüfen

Self-reported symptom experience of critically ill cancer patients receiving intensive care

Critical care medicine, 2001-02, Vol.29 (2), p.277-282

2001

Link zum Volltext

Verfügbarkeit prüfen

Effect of short-term cold exposure on skeletal muscle protein breakdown in rats

Journal of applied physiology (1985), 2013-11, Vol.115 (10), p.1496-1505

2013

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 2.273

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.684)
Mit Volltextzugriff
(1.776)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

4 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.257)
Life Sciences & Biomedicine
(826)
Humans
(818)
Male
(441)
Female
(433)
Adult
(335)
Biological And Medical Sciences
(334)
Technology
(322)
Middle Aged
(303)
Medical Sciences
(281)
Physical Sciences
(228)
Engineering
(200)
Aged
(196)
Animals
(161)
Physics
(160)
Engineering, Electrical & Electronic
(154)
Neurosciences & Neurology
(140)
Infectious Diseases
(110)
Clinical Neurology
(108)
Telecommunications
(102)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Sex-dependent effects of the uncompetitive N-methyl-D-aspartate receptor antagonist REL-1017 in G93A-SOD1 amyotrophic lateral sclerosis mice

Esmethadone-HCl (REL-1017): a promising rapid antidepressant

Behavioral Demonstration of a Somatosensory Neuroprosthesis

Influence of the addition of montmorillonite to the matrix of unidirectional glass fibre/epoxy composites on their mechanical and water absorption properties

Fully bio-based and biodegradable polylactic acid/poly(3-hydroxybutirate) blends: Use of a common plasticizer as performance improvement strategy

REL-1017 (esmethadone; d-methadone) does not cause reinforcing effect, physical dependence and withdrawal signs in Sprague Dawley rats

Enhancement of paperboard performance as packaging material by layering with plasticized polyhydroxybutyrate/nanocellulose coatings

Influence of organically modified clays on the properties and disintegrability in compost of solution cast poly(3-hydroxybutyrate) films

The novel uncompetitive NMDA receptor antagonist esmethadone (REL-1017) has no meaningful abuse potential in recreational drug users

Bilayer biocomposites based on coated cellulose paperboard with films of polyhydroxybutyrate/cellulose nanocrystals

Imaging Systems for GI Endoscopy, and Graphs in Biomedical Image Analysis: First MICCAI Workshop, ISGIE 2022, and Fourth MICCAI Workshop, GRAIL 2022, Held in Conjunction with MICCAI 2022, Singapore, September 18, 2022, Proceedings

Esmethadone (REL-1017) and Other Uncompetitive NMDAR Channel Blockers May Improve Mood Disorders via Modulation of Synaptic Kinase-Mediated Signaling

REL-1017 (Esmethadone), A Novel NMDAR Blocker for the Treatment of MDD is Not Neurotoxic in Sprague-Dawley Rats

Effect of Natural Glyceryl Tributyrate as Plasticizer and Compatibilizer on the Performance of Bio-Based Polylactic Acid/poly(3-hydroxybutyrate) Blends

Impact of different nanoparticles on the thermal degradation kinetics of phenolic resin nanocomposites

REL-1017 (Esmethadone) Increases Circulating BDNF Levels in Healthy Subjects of a Phase 1 Clinical Study

Myostatin promotes distinct responses on protein metabolism of skeletal and cardiac muscle fibers of rodents

Polyhydroxybutyrate-Based Nanocomposites with Cellulose Nanocrystals and Bacterial Cellulose

Drug–Drug Interaction Studies of Esmethadone (REL-1017) Involving CYP3A4- and CYP2D6-Mediated Metabolism

Ternary nanocomposites based on plasticized poly(3-hydroxybutyrate) and nanocellulose

The N-Methyl-D-Aspartate Receptor Blocker REL-1017 (Esmethadone) Reduces Calcium Influx Induced by Glutamate, Quinolinic Acid, and Gentamicin

Non-isothermal crystallization kinetics from the melt of nanocomposites based on poly(3-hydroxybutyrate) and modified clays

Pharmacological Comparative Characterization of REL-1017 (Esmethadone-HCl) and Other NMDAR Channel Blockers in Human Heterodimeric N-Methyl-D-Aspartate Receptors

Self-reported symptom experience of critically ill cancer patients receiving intensive care

Effect of short-term cold exposure on skeletal muscle protein breakdown in rats

Suchergebnisse filtern